BenzingaWed, 29 Apr 2026 12:27:32 GMTJim Cramer: This Tech Stock Is A 'Winner', Snap Does Not Have GrowthJNJ-1.01%
Zacks Investment ResearchTue, 28 Apr 2026 17:15:16 GMTJ&J Sees Continued MedTech Improvement in Q1, Eyes Better 2026JNJ-1.01%
Zacks Investment ResearchMon, 27 Apr 2026 17:21:10 GMTGoldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to WatchJNJ-1.01%
Zacks Investment ResearchWed, 22 Apr 2026 14:01:17 GMTJohnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should KnowJNJ-1.01%
Zacks Investment ResearchWed, 22 Apr 2026 13:35:35 GMTJ&J Innovative Medicine Drives Q1 Strength: Key to Long-Term Growth?JNJ-1.01%
24/7 Wall StreetMon, 20 Apr 2026 16:35:04 GMTPut $5,000 In These Dividend Giants and Earn Passive Income Every QuarterJNJ-1.01%
Zacks Investment ResearchMon, 20 Apr 2026 14:16:56 GMTHow to Play J&J Stock Post a Beat-and-Raise Performance in Q1JNJ-1.01%
The Motley FoolSat, 18 Apr 2026 12:30:00 GMTIs Johnson & Johnson a Buy After Its Q1 2026 Earnings Report?JNJ-1.01%
Zacks Investment ResearchFri, 17 Apr 2026 12:52:07 GMT5 Dividend Stocks Boost Payouts as Markets Reel Under Inflation FearsJNJ-1.01%
The Motley FoolThu, 16 Apr 2026 19:28:00 GMTThis "Boring" Dividend King Is Quietly Turning Into a Growth MachineJNJ-1.01%
The Motley FoolThu, 16 Apr 2026 17:47:00 GMT3 Healthcare Stocks That Have Held Up in Every Market DownturnJNJ-1.01%
24/7 Wall StreetThu, 16 Apr 2026 16:26:09 GMTCoca-Cola vs. Johnson & Johnson: The Safest Dividend on Wall Street Might Surprise YouJNJ-1.01%
Zacks Investment ResearchThu, 16 Apr 2026 14:46:28 GMTJ&J Targets Double-Digit Growth by 2030 Despite Stelara DragJNJ-1.01%
BenzingaThu, 16 Apr 2026 14:16:43 GMTEli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & JohnsonJNJ-1.01%
BenzingaWed, 15 Apr 2026 17:43:52 GMTThese Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 ResultsJNJ-1.01%
Zacks Investment ResearchWed, 15 Apr 2026 16:46:12 GMTJohnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?JNJ-1.01%
BenzingaWed, 15 Apr 2026 16:37:04 GMTJohnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish AnalystJNJ-1.01%
